But experts said the deal would not be prevented by those changes.
The new group would have combined sales of $60 billion, which would put it way ahead of the current world leader in drugs sales, Merck, with sales of $40 billion.
The takeover will also be the largest of the year, comfortably outstripping AB InBev’s $107 billion takeover of rival brewer SABMiller.